BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,587 | -24.7% | 66 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $2,107 | +4.3% | 66 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,021 | -21.7% | 66 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,581 | +158.1% | 66 | +340.0% | 0.00% | +100.0% |
| Q3 2022 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |